 AUSTIN, Texas and SHENZHEN, China, June 24, 2021 PRNewswire -- Natera, Inc. NASDAQ: NTRA, a pioneer and global leader in cell-free DNA cfDNA testing, and BGI Genomics Co., Ltd. , 300676.SZ, one of the worlds leading genomics companies, today announced the launch of the BGINatera Signatera Assay which is now available to biopharmaceutical customers and clinicians across China. 